blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1807055

EP1807055 - PROCESS FOR FORMING AMORPHOUS ATORVASTATIN [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.01.2010
Database last updated on 12.07.2024
Most recent event   Tooltip15.01.2010Application deemed to be withdrawnpublished on 17.02.2010  [2010/07]
Applicant(s)For all designated states
Warner-Lambert Company LLC
235 East 42nd Street
New York, NY 10017 / US
[2007/29]
Inventor(s)01 / DEBETTENCOURT III, Antone, John
Pfizer Global Research and Development
Eastern Point Road, Groton, CT 06340 / US
02 / ROSE, Peter, Robert
Pfizer Global Research and Development
Eastern Point Road, Groton, CT 06340 / US
03 / SHALAEV, Evgenyi, Yur'evich
Pfizer Global Research and Development
Eastern Point Road, Groton, CT 06340 / US
04 / QUALLICH, George, Joseph
Pfizer Global Research and Development
Eastern Point Road, Groton, CT 06340 / US
05 / ZIEGLER, Carl, Bernard
Pfizer Global Research and Development
Eastern Point Road, Groton, CT 06340 / US
 [2007/29]
Representative(s)Rudge, Andrew John
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [2007/29]Rudge, Andrew John
Pfizer Limited European Patent Department Ramsgate Road
Sandwich CT13 9NJ / GB
Application number, filing date05796593.112.10.2005
[2007/29]
WO2005IB03173
Priority number, dateUS20040623086P28.10.2004         Original published format: US 623086 P
[2007/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006046109
Date:04.05.2006
Language:EN
[2006/18]
Type: A1 Application with search report 
No.:EP1807055
Date:18.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2006 takes the place of the publication of the European patent application.
[2007/29]
Search report(s)International search report - published on:EP04.05.2006
ClassificationIPC:A61K9/19, A61K31/40
[2007/29]
CPC:
C07D207/34 (EP,US); A61K9/19 (EP,KR,US); A61K31/40 (EP,KR,US);
A61K9/145 (EP,US); A61K9/146 (EP,US); A61P19/10 (EP);
A61P25/28 (EP); A61P3/06 (EP); A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/29]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON AMORPHEM ATORVASTATIN[2007/29]
English:PROCESS FOR FORMING AMORPHOUS ATORVASTATIN[2007/29]
French:PROCEDE DE FORMATION D'ATORVASTATINE AMORPHE[2007/29]
Entry into regional phase29.05.2007National basic fee paid 
29.05.2007Designation fee(s) paid 
29.05.2007Examination fee paid 
Examination procedure18.01.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.05.2007Examination requested  [2007/29]
07.04.2009Despatch of a communication from the examining division (Time limit: M04)
18.08.2009Application deemed to be withdrawn, date of legal effect  [2010/07]
23.09.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/07]
Fees paidRenewal fee
31.10.2007Renewal fee patent year 03
31.10.2008Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.200905   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9703960  (WARNER LAMBERT CO [US], et al) [Y] 1-15 * page 3, lines 16-28 * * page 4, line 1 - page 7, line 20; figures 1-3; claims 1-8 *;
 [Y]US6274740  (LIN MIN [US], et al) [Y] 1-15 * column 2, line 49 - column 5, line 4; figures 1-3; examples 1,2; claims 1-3 *;
 [A]WO02083637  (CADILA HEALTHCARE LTD [IN], et al) [A] 1-15 * the whole document *;
 [A]US6528660  (KUMAR YATENDRA [IN], et al) [A] 1-15* the whole document *;
 [Y]US2004186162  (POORNAPRAJNA ACHARYA [IN], et al) [Y] 1-15 * paragraphs [0012] - [0039]; examples 1,5; claims 1,2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.